These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 22269348)

  • 21. Characteristics, treatment patterns and outcomes of patients with small cell lung cancer--a retrospective single institution analysis.
    Hermes A; Waschki B; Gatzemeier U; Reck M
    Lung Cancer; 2011 Mar; 71(3):363-6. PubMed ID: 20619477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study.
    You B; Tranchand B; Girard P; Falandry C; Ribba B; Chabaud S; Souquet PJ; Court-Fortune I; Trillet-Lenoir V; Fournel C; Tod M; Freyer G
    Lung Cancer; 2008 Nov; 62(2):261-72. PubMed ID: 18442869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.
    Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N
    Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omitting elective nodal irradiation and irradiating postinduction versus preinduction chemotherapy tumor extent for limited-stage small cell lung cancer: interim analysis of a prospective randomized noninferiority trial.
    Hu X; Bao Y; Zhang L; Guo Y; Chen YY; Li KX; Wang WH; Liu Y; He H; Chen M
    Cancer; 2012 Jan; 118(1):278-87. PubMed ID: 21598237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of preexisting interstitial lung disease in Japanese patients with small-cell lung cancer.
    Togashi Y; Masago K; Handa T; Tanizawa K; Okuda C; Sakamori Y; Nagai H; Kim YH; Mishima M
    Clin Lung Cancer; 2012 Jul; 13(4):304-11. PubMed ID: 22169479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical analysis of 126 patients with primary small cell carcinoma of the esophagus].
    Lü JM; Liang J; Wang JW; He J; Xiao ZF; Zhang HX; Chen DF; Feng QF; Wang LH
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):121-5. PubMed ID: 19538888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cisplatin and etoposide chemotherapy combined with early concurrent twice-daily thoracic radiotherapy for limited-disease small cell lung cancer in elderly patients.
    Okamoto K; Okamoto I; Takezawa K; Tachibana I; Fukuoka M; Nishimura Y; Nakagawa K
    Jpn J Clin Oncol; 2010 Jan; 40(1):54-9. PubMed ID: 19837690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications.
    Micke P; Basrai M; Faldum A; Bittinger F; Rönnstrand L; Blaukat A; Beeh KM; Oesch F; Fischer B; Buhl R; Hengstler JG
    Clin Cancer Res; 2003 Jan; 9(1):188-94. PubMed ID: 12538468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The occurrence of hyponatremia in SCLC and the influence on prognosis: a retrospective study of 453 patients treated in a single institution in a 10-year period.
    Hansen O; Sørensen P; Hansen KH
    Lung Cancer; 2010 Apr; 68(1):111-4. PubMed ID: 19535164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come.
    Brock MV; Hooker CM; Syphard JE; Westra W; Xu L; Alberg AJ; Mason D; Baylin SB; Herman JG; Yung RC; Brahmer J; Rudin CM; Ettinger DS; Yang SC
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):64-72. PubMed ID: 15632826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recent progress in chemotherapy for advanced lung cancer].
    Negoro S; Fukuoka M
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):451-60. PubMed ID: 7887637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer].
    Bozóky G; Ruby E; Góhér I; Gábor G; Mohos A; Lengyel M
    Orv Hetil; 2005 Jul; 146(27):1433-8. PubMed ID: 16089103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CEA is an independent prognostic indicator that is associated with reduced survival and liver metastases in SCLC.
    Yang X; Wang D; Yang Z; Qing Y; Zhang Z; Wang G; Yang Z; Wang Z
    Cell Biochem Biophys; 2011 Mar; 59(2):113-9. PubMed ID: 20945115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combined surgical treatment for limited small cell lung cancer: clinical analysis of 51 cases].
    Su XD; Huang ZF; Rong TH; Yang MT
    Ai Zheng; 2003 Oct; 22(10):1099-101. PubMed ID: 14558961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is neoadjuvant chemotherapy mandatory for limited-disease small-cell lung cancer?
    Xu YJ; Zheng H; Gao W; Jiang GN; Xie HK; Chen C; Fei K
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):887-93. PubMed ID: 25156899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Important prognostic factors for the long-term survival of lung cancer subjects in Taiwan.
    Chiang TA; Chen PH; Wu PF; Wang TN; Chang PY; Ko AM; Huang MS; Ko YC
    BMC Cancer; 2008 Nov; 8():324. PubMed ID: 18992131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase II study of amrubicin and topotecan combination therapy in patients with relapsed or extensive-disease small-cell lung cancer: Okayama Lung Cancer Study Group Trial 0401.
    Nogami N; Hotta K; Kuyama S; Kiura K; Takigawa N; Chikamori K; Shibayama T; Kishino D; Hosokawa S; Tamaoki A; Harita S; Tabata M; Ueoka H; Shinkai T; Tanimoto M
    Lung Cancer; 2011 Oct; 74(1):80-4. PubMed ID: 21334093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance status and sensitivity to first-line chemotherapy are significant prognostic factors in patients with recurrent small cell lung cancer receiving second-line chemotherapy.
    Kim YH; Goto K; Yoh K; Niho S; Ohmatsu H; Kubota K; Saijo N; Nishiwaki Y
    Cancer; 2008 Nov; 113(9):2518-23. PubMed ID: 18780323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combined modality therapy for small cell lung cancer patient with limited stage disease].
    Wang HJ; Sun KL; Zhang XR; Sun Y; Shi YK
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):701-3. PubMed ID: 18246803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
    Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK;
    J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.